FDA Warns Of Health Risk Posed By Cholesterol, Heart Drug Combo

August 11, 2008

The U.S. Food and Drug Administration (FDA) has come out and warned of a health risk posed when combining simvastatin, a drug to treat high cholesterol, and amiodarone, a drug used to treat irregular heart beats....Washington (ChattahBox) – The U.S. Food and Drug Administration (FDA) has come out and warned of a health risk posed when combining simvastatin, a drug to treat high cholesterol, and amiodarone, a drug used to treat irregular heart beats.

The FDA has warned against the combination of these two drugs, stating they can cause serious harm to patients.

Simvastatin is known better as Zocor of Vytorin, while amiodarone is known better as Pacerone, or Cordarone.

The FDA stated that when combined, these drugs can cause severe muscle damage, known as rhabdomyolysis, resulting in kidney failure, as well as death in some patients.


Comments

Got something to say? **Please Note** - Comments may be edited for clarity or obscenity, and all comments are published at the discretion of ChattahBox.com - Comments are the opinions of the individuals leaving them, and not of ChattahBox.com or its partners. - Please do not spam or submit comments that use copyright materials, hearsay or are based on reports where the supposed fact or quote is not a matter of public knowledge are also not permitted.